{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:25:35Z","timestamp":1789925135021,"version":"4.0.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/jcp.0b013e31829057ae","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T15:27:22Z","timestamp":1371137242000},"page":"507-511","source":"Crossref","is-referenced-by-count":22,"title":["Agomelatine in the Treatment of Fibromyalgia"],"prefix":"10.1097","volume":"33","author":[{"given":"Antonio","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Mic\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Cogliandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Pandolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Caminiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco A.","family":"Zoccali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.A.","family":"Muscatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210128","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the multicenter criteria committee.","volume":"36","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R2-9-20210128","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrrheum.2011.216","article-title":"Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria.","volume":"8","author":"McBeth","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"R3-9-20210128","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.semarthrit.2008.12.003","article-title":"Prevalence of fibromyalgia: a survey in five European countries.","volume":"39","author":"Branco","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"R4-9-20210128","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age of onset distributions of DSM IV disorders in the National Comorbidity Survey Replication.","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R5-9-20210128","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4088\/JCP.v67n0807","article-title":"Comorbidity of fibromyalgia and psychiatric disorders.","volume":"67","author":"Arnold","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R6-9-20210128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pain.2008.10.022","article-title":"Premorbid psychosocial factors are associated with poor health-related quality of life in subjects with new onset of chronic widespread painresults from the EPIFUND study.","volume":"141","author":"Nicholl","year":"2009","journal-title":"Pain"},{"key":"R7-9-20210128","doi-asserted-by":"crossref","first-page":"863","DOI":"10.4088\/JCP.v64n0801","article-title":"Here today and not gone tomorrow: the curse of chronic pain and other central sensitization syndromes.","volume":"64","author":"Stahl","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R8-9-20210128","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ncprheum0221","article-title":"Therapy Insight: fibromyalgiaa different type of pain needing a different type of treatment.","volume":"2","author":"Dadabhoy","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"R10-9-20210128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2265.1998.00503.x","article-title":"Fibromyalgiaa syndrome with decreased nocturnal melatonin secretion.","volume":"49","author":"Wikner","year":"1998","journal-title":"Clin Endocrinol"},{"key":"R11-9-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.rhu.0000120895.20623.9f","article-title":"The prevalence and clinical impact of reported cognitive difficulties (fibrofog) in patients with rheumatic disease with and without fibromyalgia.","volume":"10","author":"Katz","year":"2004","journal-title":"J Clin Rheumatol"},{"key":"R12-9-20210128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2474-8-27","article-title":"An Internet survey of 2,596 people with fibromyalgia.","volume":"8","author":"Bennett","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"issue":"suppl 2","key":"R13-9-20210128","first-page":"20","article-title":"Fibromyalgia and cognition.","volume":"69","author":"Glass","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R14-9-20210128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0022-3999(02)00628-1","article-title":"Neuropsychological impairment in fibromyalgia: relation to depression, fatigue, and pain.","volume":"55","author":"Suhr","year":"2003","journal-title":"J Psychosom Res"},{"key":"R15-9-20210128","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/jama.2008.944","article-title":"Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis.","volume":"301","author":"Hauser","year":"2009","journal-title":"JAMA"},{"key":"R16-9-20210128","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-079X.2010.00836.x","article-title":"Adjuvant use of melatonin for treatment of fibromyalgia.","volume":"50","author":"Hussain","year":"2011","journal-title":"J Pineal Res"},{"key":"R18-9-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R19-9-20210128","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating.","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"R20-9-20210128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archpsyc.1965.01720310065008","article-title":"A self-rating depression scale.","volume":"12","author":"Zung","year":"1965","journal-title":"Arch Gen Psychiatry"},{"key":"R21-9-20210128","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0033-3182(71)71479-0","article-title":"A rating instrument for anxiety disorders.","volume":"12","author":"Zung","year":"1971","journal-title":"Psychosomatics"},{"key":"R23-9-20210128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00012272-198510000-00005","article-title":"Quality of life index: development and psychometric properties.","volume":"8","author":"Ferrans","year":"1985","journal-title":"ANS Adv Nurs Sci"},{"key":"R27-9-20210128","first-page":"1115","article-title":"Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect Arch Gen Psychiatry.","volume":"64","author":"Goldberg","year":"2007","journal-title":""},{"issue":"3","key":"R28-9-20210128","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1600-079X.2011.00895.x","article-title":"Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies.","volume":"51","author":"Wilhelmsen","year":"2011","journal-title":"J Pineal Res"},{"key":"R29-9-20210128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain.","volume":"66","author":"Millan","year":"2002","journal-title":"Prog Neurobiol"},{"key":"R30-9-20210128","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jpsychores.2007.08.009","article-title":"Emotions and emotional approach and avoidance strategies in fibromyalgia.","volume":"64","author":"van Middendorp","year":"2008","journal-title":"J Psychosom Res"},{"key":"R31-9-20210128","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s11606-010-1418-6","article-title":"Sustained pain reduction through affective self-awareness in fibromyalgia: a randomized controlled trial.","volume":"25","author":"Hsu","year":"2010","journal-title":"J Gen Intern Med"},{"key":"R32-9-20210128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-0327(99)00156-1","article-title":"Discrepancies between self and observer ratings of depression. The relationship to demographic, clinical and personality variables.","volume":"60","author":"Enns","year":"2000","journal-title":"J Affect Disord"},{"key":"R33-9-20210128","first-page":"246","article-title":"A comparison of self- reported versus clinician-related symptoms in depression.","volume":"48","author":"Rush","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"R34-9-20210128","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1471-2474-10-162","article-title":"Cognitive impairment in patients with fibromyalgia syndrome as assessed by the mini-mental state examination.","volume":"21","author":"Rodriguez-Andreu","year":"2009","journal-title":"BMC Musculoskelet Disord"},{"key":"R35-9-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/hup.1094","article-title":"The use of antidepressants in clinical practice: focus on agomelatine.","volume":"25","author":"McAllister-Williams","year":"2010","journal-title":"Hum Psychopharmacol"},{"key":"R36-9-20210128","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/157015910792246227","article-title":"A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.","volume":"8","author":"Fornaro","year":"2010","journal-title":"Curr Neuropharmacol"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e31829057ae","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:01:32Z","timestamp":1620957692000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201308000-00009"}},"subtitle":["A 12-Week, Open-Label, Uncontrolled Preliminary Study"],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31829057ae","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}